18 June 2013
Keywords: eisai, china, enters, repackaging, sales, deal, stada
Article | 11 August 2008
The Chinese unit of Japanese drugmaker Eisai has entered into license agreement with Health Vision Enterprise, a sales subsidiary of
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 August 2008
4 August 2008
18 August 2008
© 2013 thepharmaletter.com